Tumor Niche Disruption and Metastasis: The Role of Epithelial-Mesenchymal Transition (EMT)

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Molecular and Cell Biology of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-030-11812-9_9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

  2019cited by this paper
• EMT in cancer

  2018cited by this paper
• The "beginnings" of the neural crest.

  2018cited by this paper
• Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer

  2017cited by this paper
• EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression

  2017cited by this paper
• EMT‐ and MET‐related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities

  2017cited by this paper
• Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity.

  2017cited by this paper
• Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory

  2017cited by this paper
• Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.

  2017cited by this paper
• Emerging Biological Principles of Metastasis.

  2017cited by this paper
• Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity

  2017cited by this paper
• Pre-metastatic niches: organ-specific homes for metastases

  2017cited by this paper
• Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy

  2017cited by this paper
• Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis

  2017cited by this paper
• EMT: Mechanisms and therapeutic implications

  2017cited by this paper
• Reprogramming to developmental plasticity in cancer stem cells.

  2017cited by this paper
• The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer

  2017cited by this paper
• Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer

  2017cited by this paper
• New insights into the role of EMT in tumor immune escape

  2017cited by this paper
• Cancer stem cells as functional biomarkers

  2017cited by this paper
• Long non-coding RNA regulation of epithelial–mesenchymal transition in cancer metastasis

  2016cited by this paper
• Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis

  2016cited by this paper
• EMT is not required for lung metastasis but contributes to chemoresistance

  2016cited by this paper
• EMT: 2016.

  2016cited by this paper
• Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks

  2016cited by this paper
• Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity

  2016cited by this paper
• A collective route to metastasis: Seeding by tumor cell clusters

  2016cited by this paper
• Effect of low doses of actinomycin D on neuroblastoma cell lines

  2016cited by this paper
• Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?

  2016cited by this paper
• Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes

  2016cited by this paper
• EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer

  2015cited by this paper
• Circulating cancer stem cells: the importance to select.

  2015cited by this paper
• An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies.

  2015cited by this paper
• Tumour exosome integrins determine organotropic metastasis

  2015cited by this paper
• Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition.

  2015cited by this paper
• Signaling mechanisms of the epithelial-mesenchymal transition

  2014cited by this paper
• Transient SNAIL1 expression is necessary for metastatic competence in breast cancer.

  2014cited by this paper
• Oncogenic roles of EMT-inducing transcription factors

  2014cited by this paper
• Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis.

  2014cited by this paper
• Regulation of the protein stability of EMT transcription factors

  2014cited by this paper
• Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition

  2014cited by this paper
• Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects.

  2014cited by this paper
• Multilayer control of the EMT master regulators

  2014cited by this paper
• Drug Resistance in Cancer: An Overview

  2014cited by this paper
• Digging a little deeper: the stages of invadopodium formation and maturation.

  2014cited by this paper
• A Review on the Biology of Cancer Stem Cells

  2014cited by this paper
• Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression

  2014cited by this paper
• Use of Epigenetic Drugs in Disease: An Overview

  2014cited by this paper
• Molecular mechanisms of epithelial–mesenchymal transition

  2014cited by this paper
• The epigenetics of epithelial-mesenchymal plasticity in cancer

  2013cited by this paper
• Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?

  2013cited by this paper
• The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.

  2013cited by this paper
• MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.

  2013cited by this paper
• Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy.

  2013cited by this paper
• EMT in developmental morphogenesis.

  2013cited by this paper
• Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells

  2013cited by this paper
• Cancer heterogeneity: implications for targeted therapeutics

  2013cited by this paper
• Control of metastatic progression by microRNA regulatory networks

  2013cited by this paper
• Riding the crest of the wave: parallels between the neural crest and cancer in epithelial-to-mesenchymal transition and migration

  2013cited by this paper
• Tumor metastasis: moving new biological insights into the clinic

  2013cited by this paper
• Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression.

  2013cited by this paper
• Cancer Development, Progression, and Therapy: An Epigenetic Overview

  2013cited by this paper
• An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)

  2013cited by this paper
• A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.

  2013cited by this paper
• Regulatory networks defining EMT during cancer initiation and progression

  2013cited by this paper
• Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

  2013cited by this paper
• Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy

  2013cited by this paper
• The myofibroblast matrix: implications for tissue repair and fibrosis

  2013cited by this paper
• Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.

  2012cited by this paper
• Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

  2012cited by this paper
• Classifying collective cancer cell invasion

  2012cited by this paper
• Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion

  2012cited by this paper
• Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells

  2012cited by this paper
• Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration.

  2012cited by this paper
• The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis

  2012cited by this paper
• Cancer stem cells and EMT in carcinoma

  2012cited by this paper
• Concordant Promoter Methylation of Transforming Growth Factor-Beta Receptor Types I and II Occurs Early in Esophageal Squamous Cell Carcinoma

  2012cited by this paper
• To differentiate or not — routes towards metastasis

  2012cited by this paper
• The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity.

  2012cited by this paper
• Early events in cell adhesion and polarity during epithelial-mesenchymal transition

  2012cited by this paper
• Cancer stem cells: current status and evolving complexities.

  2012cited by this paper
• Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition.

  2012cited by this paper
• Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT)

  2012cited by this paper
• The tumor microenvironment at a glance

  2012cited by this paper
• RNA therapeutics: beyond RNA interference and antisense oligonucleotides

  2012cited by this paper
• Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

  2012cited by this paper
• Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.

  2011cited by this paper
• A Perspective on Cancer Cell Metastasis

  2011cited by this paper
• The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Twist2 contributes to breast cancer progression by promoting an epithelial–mesenchymal transition and cancer stem-like cell self-renewal

  2011cited by this paper
• Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation

  2011cited by this paper
• FGF signalling through RAS/MAPK and PI3K pathways regulates cell movement and gene expression in the chicken primitive streak without affecting E-cadherin expression

  2011cited by this paper
• Tumor angiogenesis: molecular pathways and therapeutic targets

  2011cited by this paper
• Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative.

  2011cited by this paper
• Tumor metastasis: molecular insights and evolving paradigms.

  2011cited by this paper
• Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition

  2010cited by this paper
• A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

  2010cited by this paper
• Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.

  2010cited by this paper
• Keeping in touch with contact inhibition of locomotion

  2010cited by this paper

• Stem Cells in Urology

  2020cites this paper
• Cancer Stem Cells

  2020cites this paper